| Age in years, median (IQR) |
2.4 (0.6–6) |
2.2 (1.0–5.5) |
0.952 |
| Males, N (%) |
92 (52.9) |
83 (56.5) |
0.595 |
| Deaths, N (%) |
14 (8) |
27 (18.4) |
0.010 |
| Complicated course, N (%) |
37 (21.2) |
51 (34.7) |
0.010 |
| PRISM score, median (IQR) |
11 (7–17.3) |
16 (11–22) |
<0.001 |
| Mean days to death ± SD |
5.9±7.7 |
4.7±4.9 |
0.540 |
| Median days to death (IQR) |
3 (1–6) |
3 (2–6) |
0.759 |
| PERSEVERE-based mortality probability,mean (95% C.I.) |
11.2% (8.7–13.7) |
14.8% (11.7–17.9) |
0.191 |
| Maximum number of organ failures, median (IQR) |
2 (1–3) |
2 (2–3) |
0.020 |
| Number of vasoactive agents at the time ofcorticosteroid initiation, median (IQR) |
– |
2 (1–3) |
– |
| Maximum number of simultaneous vasoactiveagents during the first 7 days, median (IQR) |
1 (1–2) |
2 (1–3) |
<0.001 |
| Gram-positive bacteria, N (%) |
44 (25.3) |
36 (24.7) |
1.000 |
| Gram-negative bacteria, N (%) |
24 (13.8) |
29 (19.9) |
0.192 |
| Other organism, N (%) |
10 (5.7) |
16 (11) |
0.135 |
| Negative cultures, N (%) |
95 (54.6) |
66 (45.2) |
0.118 |
